Relationship between glomerular dysfunction and left-ventricular mass independent of haemodynamic factors in a community sample

Journal of Hypertension

Volumn 31, Issue 3, 2013, Pages 568-575

  Maunganidze, Fabian ^a   Norton, Gavin R ^a   Maseko, Muzi J ^a   Libhaber, Carlos D ^a,b   Majane, Olebogeng H I ^a   Sareli, Pinhas ^a   Woodiwiss, Angela J ^a  

^a UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Glomerular filtration rate; Left ventricular hypertrophy; Microalbuminuria

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE;

ADULT; AORTA; AORTA PRESSURE; APPLANATION TONOMETER; ARTICLE; BLOOD PRESSURE; CHRONIC KIDNEY DISEASE; COMMUNITY SAMPLE; ECHOCARDIOGRAPHY; FEMALE; GLOMERULAR DYSFUNCTION; GLOMERULUS FILTRATION RATE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE MASS; HEART STROKE VOLUME; HEART VENTRICLE SIZE; HEART VENTRICLE WALL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSE WAVE; STROKE WORK; WALL STRESS; GLOMERULUS; HEART VENTRICLE; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; FEMALE; GLOMERULAR FILTRATION RATE; HEART VENTRICLES; HUMANS; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84884175244     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32835cd607     Document Type: Article

References (42)

1. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 1999; 56:853-906.
2. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Int Med 2001; 134:629-636. (Pubitemid 32322240)
3. Sclipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Int Med 2002; 137:555-562.
4. Henry RM, Kostense PJ, Bos G, Dekker JM, Nijpels G, Heine RJ, et al. Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. Kidney Int 2002; 62:1402-1407.
5. Manjunath G, Tighouart H, Coresh J, Macleod B, Salem DN, Griffith JL, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 2003; 41:47-55. (Pubitemid 36044403)
6. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalisation. N Engl J Med 2004; 351:1296-1305.
7. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relations between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351:1285-1295. (Pubitemid 39258422)
8. Farbom P, Wahlstrand B, Almgren P, Skrtic S, Lanke J, Weiss L, et al. Interaction between renal function and microalbuminuria for cardiovascular risk in hypertension: The Nordic Diltiazem Study. Hypertension 2008; 52:115-122.
9. Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lameire N. European uremic Toxin Work Group. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 2005; 20:1048-1056. (Pubitemid 40862092)
10. Hallen S, Astor B, Romundstad S, Aasarod K, Kvenild K, Coresh J. Association of kidney function and albuminuria with cardiovascular mortality in older vs. younger individuals. The HUNT II Study. Arch Int Med 2007; 167:2490-2496. (Pubitemid 350254909)
11. McCullough PA, Jurkovitz CT, Pergola PE, McGill JB, Brown WW, Collins AJ, et al., for the KEEP Investigators. Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). Arch Int Med 2007; 167:1122-1129. (Pubitemid 46919814)
12. Foster MC, Hwang SJ, Larson MG, Parikh NI, Meigs JB, Vasan RS, et al. Cross-classification of microalbuminuria and reduced glomerular filtration rate: associations between cardiovascular disease risk factors and clinical outcomes. Arch Int Med 2007; 167:1386-1392. (Pubitemid 47052437)
13. Cirillo M, Lanti MP, Menotti A, Lorenzi M, Mancini M, Zanchetti A, De Santo NG. Definition of kidney disease as a cardiovascular risk factor: use of albumin excretion and estimated glomerular filtration rate. Arch Int Med 2008; 168:617-624. (Pubitemid 351471667)
14. Fliser D, Pacini G, Engelleiter R, Kautzky-Willer A, Prager R, Franek E, Ritz E. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 1998; 53:1343-1347. (Pubitemid 28316896)
15. Kronenberg F, Kuen E, Ritz E, Junker R, Konig P, Kraatz G, et al. Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure. J Am Soc Nephrol 2000; 11:105-115. (Pubitemid 30020432)
16. Stam F, van Guldener C, Schalkwijk CG, ter Wee PM, Donker AJ, Stehouwer CD. Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity. Nephrol Dial Transplant 2003; 18:892-898. (Pubitemid 36592529)
17. Levin A, Singer J, Thompson CR, Ross H, Lewis M. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis 1996; 27:347-354. (Pubitemid 26075843)
18. Landray MJ, Thambyrajah J, McGlynn FJ, Jones HJ, Baigent C, Kendall MJ, et al. Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment. Am J Kidney Dis 2001; 38:537-546. (Pubitemid 32803065)
19. Leoncini G, Viazzi F, Parodi D, Vettoretti S, Ratto E, Ravera M, et al. Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension. Hypertension 2003; 42:14-18. (Pubitemid 36842230)
20. Leoncini G, Viazzi F, Parodi D, Ratto E, Vettoretti S, Vaccaro V, et al. Mild renal dysfunction and cardiovascular risk in hypertensive patients. J Am Soc Nephrol 2004; 15:S88-S90. (Pubitemid 38028507)
21. Henry RMA, Kamp O, Kostense PJ, Spijkerman AMW, Dekker JM, Nijpels G, et al. Mild renal insufficiency is associated with increased left ventricular mass in men, but not in women: an arterial stiffness-related phenomenon-The Hoorn Study. Kidney Int 2005; 68:673-679. (Pubitemid 43323122)
22. Paoletti E, Bellino D, Cassottano P, Rolla D, Cannella G. Left ventricular hypertrophy in nondiabetic predialysis CKD. Am J Kidney Dis 2005; 46:320-327. (Pubitemid 41040362)
23. Leoncini G, Ratto E, Viazzi F, Conti N, Falqui V, Parodi A, et al. Global risk stratification in primary hypertension: the role of the kidney. J Hypertens 2008; 26:427-432. (Pubitemid 351317250)
24. Nardi E, Palermo A, Mule G, Cusimano P, Cottone S, Cerasola G. Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease. J Hypertens 2009; 27:633-641.
25. Leoncini G, Viazzi F, Conti N, Baratto E, Tomolillo C, Bezante GP, et al. Renal and cardiac abnormalities in primary hypertension. J Hypertens 2009; 27:1064-1073.
26. Cerasola G, Nardi E, Mule G, Palermo A, Cusimano P, Guarneri M, et al. Left ventricular mass in hypertensive patients with mild-to-moderate reduction of renal function. Nephrology 2010; 15:203-210.
27. Masugata H, Senda S, Goda F, Yamagami A, Okuyama H, Kohno T, et al. Echocardiographic assessment of the cardio-renal connection: is left ventricular hypertrophy or diastolic function more closely correlated with estimated glomerular filtration rate in patients with cardiovascular risk factors? Clin Exp Hypertens 2010; 32:113-120.
28. Cioffi G, Tarantinio L, Frizzi R, Stefenelli C, Russo TE, Selmi A, et al. Chronic kidney disease elicits excessive increase in left ventricular mass growth in patients at increased risk for cardiovascular events. J Hypertens 2011; 29:565-573.
29. Norton GR, Majane OH, Maseko MJ, Libhaber C, Redelinghuys M, Kruger D, et al. Brachial blood pressure-independent relations between radial late systolic shoulder-derived aortic pressures and target organ changes. Hypertension 2012; 59:885-892.
30. Mancia G, Parati G. Ambulatory blood pressure monitoring and organ damage. Hypertension 2000; 36:894-900.
31. Redelinghuys M, Norton GR, Scott L, Maseko MJ, Brooksbank R, Majane OHI, et al. Relationship between urinary salt excretion and pulse pressure and central aortic hemodynamics independent of steady state pressure in the general population. Hypertension 2010; 56:584-590.
32. Woodiwiss AJ, Molebatsi N, Maseko MJ, Libhaber E, Libhaber C, Majane OHI, et al. Nurse-recorded auscultatory blood pressure at a single visit predicts target organ changes as well as ambulatory blood pressure. J Hypertens 2009; 27:287-297.
33. Bennett CM, Guo M, Dharmage SC. HbA1c as a screening tool for the detection of type 2 diabetes: a systematic review. Diabet Med 2007; 24:333-343. (Pubitemid 46452406)
34. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation: Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461-470. (Pubitemid 29135798)
35. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiograph assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57:450-458. (Pubitemid 16119719)
36. Woodiwiss AJ, Libhaber CD, Libhaber E, Sareli P, Norton GR. Relationship between on-treatment decreases in inappropriate versus absolute or indexed left ventricular mass and increases in ejection fraction in hypertension. Hypertension 2012; 60:810-817.
37. Casale PN, Devereux RB, Milner M, Zullo G, Harshfield GA, Pickering TG, Laragh JH. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105:173-178. (Pubitemid 16039288)
38. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographic measurement of left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561-1566. (Pubitemid 20176696)
39. Ghali JK, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS. The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med 1992; 117:831-836.
40. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA 1996; 275:1557-1562. (Pubitemid 26154241)
41. Gottdiener JS, Arnold AM, Aurigemma GP, Polak JF, Tracy RP, Kitzman DW, et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 2000; 35:1628-1637. (Pubitemid 30307510)
42. Gardin JM, McClellan R, Kitzman D, Lima JAC, Bommer W, Klopfenstein HS, et al. M-mode echocardiographic predictors of six-to-seven year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort. Am J Cardiol 2001; 87:1051-1057. (Pubitemid 32710318)